Live news related to ABIVAX stock (FR0012333284): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Abivax has announced the buyback of its Royalty Certificates. The company is also issuing $45 million (€38.5 million) in American Depositary Shares.
The French biotech progresses to €101.80 in mid-session on Monday, marking a 5.55% increase from the last close of €96.45. The movement occurs during …
French biotech company Abivax sees a 2.93% drop during Wednesday's session on April 29, trading at €92.75, in a generally declining Paris market. The …
Abivax announces the presentation of nine scientific abstracts focused on obefazimod at the Digestive Disease Week conference, scheduled from May 2 to…
Abivax announces nine scientific abstracts concerning obebazimod at the Digestive Disease Week, scheduled from May 2 to May 5, 2026, in Chicago. These…
The stock of French biotech company Abivax significantly dropped this Monday, April 13, falling to 102.40 euros after closing at 107.90 euros on Frida…
Abivax climbs 3.41% this Friday to €109.10, driven by a spectacular increase in the price target set by Oddo BHF the previous day. The French biotech …
The French biotech company's stock increased by 2.77% this Thursday to €103.80, in a declining Paris market. This rise occurs as the CAC 40 drops by 0…
On Wednesday, April 8, the stock of the French biotech company Abivax significantly advanced in a buoyant Parisian market. Abivax traded around €103.1…
The stock of the French biotech company significantly lost ground this Thursday, in a pressured Parisian market. Abivax fell by 4.41% to €97.50, dropp…
